2026 NPPES data Vision Therapy Optometrist NPI 1518960954 OD
Verify on CMS →

MICHAEL DE ROSIER, OD

Vision Therapy Optometrist in DEER PARK, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
30
Medicare Part D claims · 14 beneficiaries · Vision Therapy Optometrist avg: 209
Generic prescribing
60%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$107.55
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL DE ROSIER, OD is a Vision Therapy Optometrist ([object Object]) practicing in DEER PARK, Washington with a Medicare Part D prescribing footprint of 30 claims across 14 beneficiaries — 40% brand-name prescribing . Industry payments of $107.55 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL DE ROSIER, OD filed 30 Medicare Part D claims in 2023 across DEER PARK, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MICHAEL DE ROSIER, OD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/31/2005

NPI 1518960954

Primary specialty

Vision Therapy Optometrist

Rare

369 US NPIs in this specialty

Medicare Part D claims

30 86% vs specialty avg

2023 prescription claims

Specialty avg: 209

Specialty distribution in Washington

How Vision Therapy Optometrist compares to other specialties among Washington providers

Washington providers

Vision Therapy Optometrist share within Washington

1. Vision Therapy Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Vision Therapy Optometrist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Vision Therapy Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Vision Therapy Optometrist ABMS/AOA estimate

Est. board-certified rate (Vision Therapy Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Vision Therapy Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL DE ROSIER, OD is a Vision Therapy Optometrist provider practicing in DEER PARK, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: OD. NPI: 1518960954. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL DE ROSIER, OD appears in the CMS NPPES registry as a Vision Therapy Optometrist provider holding OD credentials at 26 W H ST, DEER PARK, WA, 99006, with a listed phone of (509) 276-6932. NPI 1518960954 was issued on 05/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DE ROSIER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 30 prescription claims written by this provider, covering 14 Medicare beneficiaries and totaling roughly $1K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Vision Therapy Optometrist is a narrow specialty nationwide, with 369 enrolled providers across 42 states and an average of 209 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

26 W H ST
DEER PARK, WA 99006

Provider Details

NPI 1518960954
Specialty Vision Therapy Optometrist
Credentials OD
Gender Male
NPI Issued 05/31/2005

Hospital and facility affiliations

Facilities where MICHAEL DE ROSIER, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FUTURE VISION PARTNERS INC
DEER PARK, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL DE ROSIER, OD. Source: openpaymentsdata.cms.gov.

Total received

$108

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MICHAEL DE ROSIER, OD. To verify MICHAEL DE ROSIER, OD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MICHAEL DE ROSIER, OD — brand share 40.0%
Specialty average (est.)

40% brand-name claims vs 60% generic, on 30 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

30
Total Claims
$1K
Total Drug Cost
14
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
49
Total Day Supply
1,268
Brand vs Generic
40% brand / 60% generic
Brand Drug Cost
$721
Generic Drug Cost
$284

Patient Demographics

Average Patient Age
75.7 years
Avg HCC Risk Score
0.98

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Vision Therapy Optometrist Overview

How MICHAEL DE ROSIER, OD fits within the Vision Therapy Optometrist landscape nationally.

369
Vision Therapy Optometrist Providers in US
42
States with Vision Therapy Optometrist
209
Avg Claims per Provider

MICHAEL DE ROSIER, OD's 30 claims are below the specialty average of 209.

Nearby Vision Therapy Optometrist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as DE ROSIER.

Compare Vision Therapy Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL DE ROSIER, OD's specialty?
MICHAEL DE ROSIER, OD specializes in Vision Therapy Optometrist and practices in DEER PARK, Washington. Credentials: OD.
How much does MICHAEL DE ROSIER, OD prescribe under Medicare Part D?
In 2023, MICHAEL DE ROSIER, OD wrote 30 Medicare Part D claims totaling $1K in drug costs for 14 beneficiaries.
Where is MICHAEL DE ROSIER, OD located?
MICHAEL DE ROSIER, OD is located at 26 W H ST, DEER PARK, WA, 99006. Phone: (509) 276-6932.
What is MICHAEL DE ROSIER, OD's NPI number?
MICHAEL DE ROSIER, OD's National Provider Identifier (NPI) is 1518960954, issued on 05/31/2005.
Does MICHAEL DE ROSIER, OD prescribe more brand-name or generic drugs?
MICHAEL DE ROSIER, OD's prescribing is 40% brand-name and 60% generic drugs by claim count, with $721 in brand drug costs.
How many Vision Therapy Optometrist providers are there in the US?
There are 369 Vision Therapy Optometrist providers across 42 states in the US. The average Vision Therapy Optometrist provider writes 209 Medicare Part D claims per year.
What drugs does MICHAEL DE ROSIER, OD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL DE ROSIER, OD's most frequently prescribed drugs include Latanoprost. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL DE ROSIER, OD accept Medicare?
MICHAEL DE ROSIER, OD appears in CMS Medicare data with 30 Part D claims and 14 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL DE ROSIER, OD's credentials?
MICHAEL DE ROSIER, OD's NPI is 1518960954 with credentials OD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology